ID/Version |
|
||||||||||||||
Sequence description from provider |
RecName: Full=Growth/differentiation factor 15 {ECO:0000303|PubMed:10779363}; Short=GDF-15 {ECO:0000303|PubMed:10779363};AltName: Full=Macrophage inhibitory cytokine 1 {ECO:0000303|PubMed:23468844}; Short=MIC-1 {ECO:0000303|PubMed:23468844 | ||||||||||||||
Provider | SWISS-PROT | ||||||||||||||
Sequence |
Polypeptide
303
aa
|
||||||||||||||
Source | |||||||||||||||
Annotated genes and markers |
Follow the symbol links to get more information on the GO terms,
expression assays, orthologs, phenotypic alleles, and other information
for the genes or markers below.
|
||||||||||||||
Sequence references in MGI |
J:61788
Hsiao EC, et al., Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury. Mol Cell Biol. 2000 May;20(10):3742-51
J:99680 The FANTOM Consortium and RIKEN Genome Exploration Research Group and Genome Science Group (Genome Network Project Core Group), The Transcriptional Landscape of the Mammalian Genome. Science. 2005;309(5740):1559-1563 J:154446 Strelau J, et al., Progressive postnatal motoneuron loss in mice lacking GDF-15. J Neurosci. 2009 Oct 28;29(43):13640-8 J:171576 Kempf T, et al., GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nat Med. 2011 May;17(5):581-8 J:197174 Tsai VW, et al., TGF-b superfamily cytokine MIC-1/GDF15 is a physiological appetite and body weight regulator. PLoS One. 2013;8(2):e55174 J:246122 Low JK, et al., First Behavioural Characterisation of a Knockout Mouse Model for the Transforming Growth Factor (TGF)-beta Superfamily Cytokine, MIC-1/GDF15. PLoS One. 2017;12(1):e0168416 J:246965 Chung HK, et al., Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis. J Cell Biol. 2017 Jan 02;216(1):149-165 J:251850 Emmerson PJ, et al., The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. Nat Med. 2017 Oct;23(10):1215-1219 J:251855 Mullican SE, et al., GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates. Nat Med. 2017 Oct;23(10):1150-1157 J:251981 Yang L, et al., GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nat Med. 2017 Oct;23(10):1158-1166 J:254140 Hsu JY, et al., Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15. Nature. 2017 Oct 12;550(7675):255-259 J:261053 Wang T, et al., GDF15 is a heart-derived hormone that regulates body growth. EMBO Mol Med. 2017 Aug;9(8):1150-1164 J:264354 Tran T, et al., GDF15 deficiency promotes high fat diet-induced obesity in mice. PLoS One. 2018;13(8):e0201584 J:283184 Xiong Y, et al., Long-acting MIC-1/GDF15 molecules to treat obesity: Evidence from mice to monkeys. Sci Transl Med. 2017 Oct 18;9(412) J:285776 Ost M, et al., Muscle-derived GDF15 drives diurnal anorexia and systemic metabolic remodeling during mitochondrial stress. EMBO Rep. 2020 Mar 4;21(3):e48804 J:292147 Coll AP, et al., GDF15 mediates the effects of metformin on body weight and energy balance. Nature. 2020 Feb;578(7795):444-448 J:292414 Johnen H, et al., Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Nat Med. 2007 Nov;13(11):1333-40 J:298668 Worth AA, et al., The cytokine GDF15 signals through a population of brainstem cholecystokinin neurons to mediate anorectic signalling. Elife. 2020 Jul 29;9:e55164 J:300248 Breen DM, et al., GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman Primates. Cell Metab. 2020 Dec 1;32(6):938-950.e6 J:304627 Klein AB, et al., Pharmacological but not physiological GDF15 suppresses feeding and the motivation to exercise. Nat Commun. 2021 Feb 15;12(1):1041 J:316128 Sabatini PV, et al., GFRAL-expressing neurons suppress food intake via aversive pathways. Proc Natl Acad Sci U S A. 2021 Feb 23;118(8):e2021357118 J:325215 Suriben R, et al., Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice. Nat Med. 2020 Aug;26(8):1264-1270 J:328108 Klein AB, et al., The GDF15-GFRAL pathway is dispensable for the effects of metformin on energy balance. Cell Rep. 2022 Aug 23;40(8):111258 J:332012 Xie B, et al., Hepatocyte-derived GDF15 suppresses feeding and improves insulin sensitivity in obese mice. iScience. 2022 Dec 22;25(12):105569 J:338885 Kim J, et al., TFEB-GDF15 axis protects against obesity and insulin resistance as a lysosomal stress response. Nat Metab. 2021 Mar;3(3):410-427 J:340165 Wang D, et al., GDF15 promotes weight loss by enhancing energy expenditure in muscle. Nature. 2023 Jul;619(7968):143-150 J:341053 Breit SN, et al., GDF15 enhances body weight and adiposity reduction in obese mice by leveraging the leptin pathway. Cell Metab. 2023 Aug 8;35(8):1341-1355.e3 J:341091 Florsheim EB, et al., Immune sensing of food allergens promotes avoidance behaviour. Nature. 2023 Aug;620(7974):643-650 J:342573 Lu JF, et al., Camptothecin effectively treats obesity in mice through GDF15 induction. PLoS Biol. 2022 Feb;20(2):e3001517 J:344181 Fejzo M, et al., GDF15 linked to maternal risk of nausea and vomiting during pregnancy. Nature. 2023 Dec 13; J:345047 Day EA, et al., Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss. Nat Metab. 2019 Dec;1(12):1202-1208 J:347515 Lu JF, et al., GDF15 is a major determinant of ketogenic diet-induced weight loss. Cell Metab. 2023 Dec 5;35(12):2165-2182.e7 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|